Risk of methicillin-resistant staphylococcus aureus prosthetic joint infection in elective total hip and knee arthroplasty following eradication therapy

doi:10.5312/wjo.v12.i11.842

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2584)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

168

WORD

134

HTML

1489

Tables (1-3)

170

Sum=1961

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

273

Download

350

Sum=623

Nov 18, 2021 (publication date) through May 17, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Orthop. Nov 18, 2021; 12(11): 842-849
Published online Nov 18, 2021. doi: 10.5312/wjo.v12.i11.842

Risk of methicillin-resistant staphylococcus aureus prosthetic joint infection in elective total hip and knee arthroplasty following eradication therapy

Benjamin Pal Kapur, Xenia Tonge, Gunasekaran Kumar

Benjamin Pal Kapur, Xenia Tonge, Gunasekaran Kumar, Trauma and Orthopaedics, Royal Liverpool University Teaching Hospitals, Liverpool L7 8XP, Merseyside, United Kingdom

Author contributions: Kapur BP, Tonge X and Kumar G contributed equally to this work.

Institutional review board statement: No ethics approval was required for this retrospective review. This study was registered with the hospitals audit department.

Conflict-of-interest statement: The authors have no relevant financial or non-financial interests to disclose.

Data sharing statement: Data is available if requested from the corresponding author at benjaminkapur@nhs.net.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Benjamin Pal Kapur, FRCS, MBChB, Surgeon, Trauma and Orthopaedics, Royal Liverpool University Teaching Hospitals, Prescott Street, Liverpool L7 8XP, Merseyside, United Kingdom. benjaminkapur@nhs.net

Received: May 12, 2021
Peer-review started: May 12, 2021
First decision: July 28, 2021
Revised: August 8, 2021
Accepted: September 29, 2021
Article in press: September 29, 2021
Published online: November 18, 2021

Core Tip

Core Tip: Retesting to ascertain true eradication of methicillin-resistant staphylococcus aureus (MRSA) prior to arthroplasty is essential. Without this, eradication treatment success remains undetermined with the resultant increased incidence of MRSA prosthetic joint infection and associated morbidity and mortality with revision surgery.